Exploration of Feasible Immune Biomarkers for Immune Checkpoint Inhibitors in Head and Neck Squamous Cell Carcinoma Treatment in Real World Clinical Practice

Recurrent locally advanced or metastatic head and neck squamous cell carcinoma (HNSCC) is associated with dismal prognosis because of its highly invasive behavior and resistance to conventional intensive chemotherapy. The combination of targeted therapy and conventional chemotherapy has significantl...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Hui-Ching, Yeh, Tsung-Jang, Chan, Leong-Perng, Hsu, Chin-Mu, Cho, Shih-Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7589088/
https://www.ncbi.nlm.nih.gov/pubmed/33076306
http://dx.doi.org/10.3390/ijms21207621

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7589088/
https://www.ncbi.nlm.nih.gov/pubmed/33076306
http://dx.doi.org/10.3390/ijms21207621

Ejemplares similares